NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Phase I:Adult patients with centrally confirmed diagnosis of advanced/metastatic undifferentiated pleomorphic sarcoma, leiomyosarcoma, myxoid/and hypercellular myxoid liposarcoma, myxofibrosarcoma, NOS sarcoma, synovial sarcoma, fibrosarcoma, malignant peripheral nerve sheath tumor, epitheloid sarcoma, pleomorphic rhabdomyosarcoma, pleomorphic liposarcoma and angiosarcoma, high-grade uterine sarcomas (excluding those with BCOR or NTRK translocation).
Phase II:Adult patients with centrally confirmed diagnosis of advanced/metastatic undifferentiated pleomorphic sarcoma or leiomyosarcoma.
1 total trials
Filter these 1 trials by phase, country, sponsor and more.